Versant Venture Capital VI, L.P. - Oct 28, 2024 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
10%+ Owner
Signature
Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Stock symbol
GLUE
Transactions as of
Oct 28, 2024
Transactions value $
-$1,491,041
Form type
4
Date filed
10/30/2024, 04:35 PM
Previous filing
Sep 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLUE Common Stock Sale -$869K -90K -4.29% $9.66 2.01M Oct 28, 2024 See Footnote F1, F2
transaction GLUE Common Stock Other $0 -1.02M -20% $0.00 4.08M Oct 28, 2024 Direct F3, F4
transaction GLUE Common Stock Other $0 +20.4K $0.00 20.4K Oct 28, 2024 See Footnote F5, F6
transaction GLUE Common Stock Other $0 -20.4K -100% $0.00 0 Oct 28, 2024 See Footnote F6, F7
transaction GLUE Common Stock Other $0 +17.6K $0.00 17.6K Oct 28, 2024 See Footnote F8, F9
transaction GLUE Common Stock Other $0 -17.6K -100% $0.00 0 Oct 28, 2024 See Footnote F9, F10
transaction GLUE Common Stock Other $0 -367K -18.26% $0.00 1.64M Oct 28, 2024 See Footnote F2, F11
transaction GLUE Common Stock Other $0 +5.5K $0.00 5.5K Oct 28, 2024 See Footnote F12, F13
transaction GLUE Common Stock Other $0 -5.5K -100% $0.00 0 Oct 28, 2024 See Footnote F13, F14
transaction GLUE Common Stock Other $0 +5.45K $0.00 5.45K Oct 28, 2024 See Footnote F15, F16
transaction GLUE Common Stock Other $0 -5.45K -100% $0.00 0 Oct 28, 2024 See Footnote F16, F17
transaction GLUE Common Stock Sale -$475K -52.3K -3.19% $9.08 1.59M Oct 29, 2024 See Footnote F2, F18
transaction GLUE Common Stock Sale -$147K -15.6K -0.98% $9.41 1.57M Oct 29, 2024 See Footnote F2, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Versant Venture Capital VI, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.50 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2 Shares held by Versant Vantage I, L.P. ("Versant Vantage I"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage I, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Versant Vantage I GP-GP and Versant Vantage I GP may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
F3 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("Versant VI") to its partners.
F4 Shares held by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Each of Versant Ventures VI GP-GP and Versant Ventures VI GP may be deemed to share voting, investment and dispositive power over the shares held by Versant VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
F5 Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI.
F6 Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the general partner of Versant Ventures VI GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Ventures VI GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.
F7 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP to its partners.
F8 Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP.
F9 Shares held by Versant Ventures VI GP-GP.
F10 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP to its members.
F11 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I to its partners.
F12 Represents a change in the form of ownership of Versant Vantage I GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I.
F13 Shares held by Versant Vantage I GP. Versant Vantage I GP-GP is the general partner of Versant Vantage I GP and may be deemed to share voting, investment and dispositive power over the shares held by Versant Vantage I GP and disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.
F14 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP to its partners.
F15 Represents a change in the form of ownership of Versant Vantage I GP-GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Vantage I GP.
F16 Shares held by Versant Vantage I GP-GP.
F17 Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I GP-GP to its members.
F18 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $8.36 to $9.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (18) to this Form 4.
F19 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $9.33 to $9.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (19) to this Form 4.